JW

James Wang

Chief Technology Officer

Juventas Cell Therapy Corp.

Princeton, New Jersey


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Juventas Cell Therapy Corp.
Industry
pharmaceuticals
Employees
30.0
Seniority
C suite
Annual Revenue
5000000.0
Total Funding
183470260.0
Latest Funding
Series C

Technologies

Microsoft Office 365 Nginx Mobile Friendly Remote AI Circle

Keywords

pharmaceutical manufacturing car-t cell therapy immunotherapy biopharmaceuticals cd19 inaticabtagene autoleucel nmpa fda breakthrough therapy designation orphan drug designation clinical trials pipeline hematologic malignancies solid tumors autoimmune diseases r&d manufacturing quality control innovative drugs patient care clinical transformation biomedical innovation cellular technologies genetic therapies therapeutic efficacy clinical applications market authorization drug production license biotech clinical research drug development cancer treatment personalized medicine therapeutic candidates biologics research foundations scientific advancements medical breakthroughs targeted therapies innovation healthcare solutions therapeutic strategies clinical efficacy safety & effectiveness treatment design fda approval nmpa approval drug applications medical products pharmaceuticals medical health care health wellness & fitness hospital & health care research & development mechanical or industrial engineering

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans